O	0	10	Inhibition	Inhibition	NN	B-NP
O	11	13	of	of	IN	B-PP
O	14	24	calmodulin	calmodulin	NN	B-NP
O	24	25	-	-	HYPH	B-NP
O	25	34	dependent	dependent	JJ	I-NP
O	35	41	myosin	myosin	NN	I-NP
O	42	47	light	light	NN	I-NP
O	47	48	-	-	HYPH	B-NP
O	48	53	chain	chain	NN	I-NP
O	54	60	kinase	kinase	NN	I-NP
O	61	63	by	by	IN	B-PP
O	64	70	growth	growth	NN	B-NP
O	70	71	-	-	HYPH	B-NP
O	71	78	hormone	hormone	NN	I-NP
O	78	79	-	-	HYPH	O
O	79	88	releasing	release	VBG	B-VP
O	89	95	factor	factor	NN	B-NP
O	96	99	and	and	CC	O
O	100	110	vasoactive	vasoactive	JJ	B-NP
B-Multi-tissue_structure	111	121	intestinal	intestinal	JJ	I-NP
O	122	129	peptide	peptide	NN	I-NP
O	129	130	.	.	.	O

O	131	133	In	In	IN	B-PP
O	134	138	view	view	NN	B-NP
O	139	141	of	of	IN	B-PP
O	142	145	the	the	DT	B-NP
O	146	153	ability	ability	NN	I-NP
O	154	156	of	of	IN	B-PP
O	157	167	calmodulin	calmodulin	NN	B-NP
O	168	170	to	to	TO	B-VP
O	171	175	bind	bind	VB	I-VP
O	176	186	vasoactive	vasoactive	JJ	B-NP
B-Multi-tissue_structure	187	197	intestinal	intestinal	JJ	I-NP
O	198	205	peptide	peptide	NN	I-NP
O	206	207	(	(	(	O
O	207	210	VIP	VIP	NN	B-NP
O	210	211	)	)	)	O
O	212	215	and	and	CC	O
O	216	222	growth	growth	NN	B-NP
O	222	223	-	-	HYPH	B-NP
O	223	230	hormone	hormone	NN	I-NP
O	230	231	-	-	HYPH	O
O	231	240	releasing	release	VBG	B-VP
O	241	247	factor	factor	NN	B-NP
O	248	249	(	(	(	O
O	249	252	GRF	GRF	NN	B-NP
O	252	253	)	)	)	O
O	254	258	with	with	IN	B-PP
O	259	263	high	high	JJ	B-NP
O	264	272	affinity	affinity	NN	I-NP
O	273	274	[	[	(	O
O	274	283	Stallwood	Stallwood	NNP	B-NP
O	283	284	,	,	,	O
O	285	292	Brugger	Brugger	NNP	B-NP
O	292	293	,	,	,	O
O	294	305	Baggenstoss	Baggenstoss	NNP	B-NP
O	305	306	,	,	,	O
O	307	314	Stemmer	Stemmer	NNP	B-NP
O	314	315	,	,	,	O
O	316	323	Shiraga	Shiraga	NNP	B-NP
O	323	324	,	,	,	O
O	325	332	Landers	Landers	NNP	B-NP
O	333	336	and	and	CC	O
O	337	341	Paul	Paul	NNP	B-NP
O	342	343	(	(	(	O
O	343	347	1992	1992	CD	B-NP
O	347	348	)	)	)	O
O	349	350	J	J	NNP	B-NP
O	350	351	.	.	.	I-NP
O	352	356	Biol	Biol	NNP	I-NP
O	356	357	.	.	.	I-NP
O	358	362	Chem	Chem	NNP	I-NP
O	362	363	.	.	.	I-NP
O	364	367	267	267	CD	I-NP
O	367	368	,	,	,	I-NP
O	369	374	19617	19617	CD	I-NP
O	374	375	-	-	HYPH	I-NP
O	375	380	19621	19621	CD	I-NP
O	380	381	]	]	)	O
O	381	382	,	,	,	O
O	383	386	the	the	DT	B-NP
O	387	394	effects	effect	NNS	I-NP
O	395	397	of	of	IN	B-PP
O	398	403	these	these	DT	B-NP
O	404	417	neuropeptides	neuropeptide	NNS	I-NP
O	418	420	on	on	IN	B-PP
O	421	422	a	a	DT	B-NP
O	423	428	model	model	NN	I-NP
O	429	439	calmodulin	calmodulin	NN	I-NP
O	439	440	-	-	HYPH	B-NP
O	440	449	dependent	dependent	JJ	I-NP
O	450	456	enzyme	enzyme	NN	I-NP
O	456	457	,	,	,	O
O	458	464	myosin	myosin	NN	B-NP
O	465	470	light	light	NN	I-NP
O	470	471	-	-	HYPH	O
O	471	476	chain	chain	NN	B-NP
O	477	483	kinase	kinase	NN	I-NP
O	484	485	(	(	(	O
O	485	489	MLCK	MLCK	NN	B-NP
O	489	490	)	)	)	O
O	490	491	,	,	,	O
O	492	496	were	be	VBD	B-VP
O	497	504	studied	study	VBN	I-VP
O	504	505	.	.	.	O

O	506	510	Both	Both	DT	B-NP
O	511	519	peptides	peptide	NNS	I-NP
O	520	524	were	be	VBD	B-VP
O	525	531	potent	potent	JJ	B-NP
O	532	542	inhibitors	inhibitor	NNS	I-NP
O	543	545	of	of	IN	B-PP
O	546	550	MLCK	MLCK	NN	B-NP
O	551	559	activity	activity	NN	I-NP
O	559	560	.	.	.	O

O	561	564	The	The	DT	B-NP
O	565	575	inhibition	inhibition	NN	I-NP
O	576	578	of	of	IN	B-PP
O	579	585	enzyme	enzyme	NN	B-NP
O	586	594	activity	activity	NN	I-NP
O	595	597	by	by	IN	B-PP
O	598	601	VIP	VIP	NN	B-NP
O	602	605	and	and	CC	I-NP
O	606	609	GRF	GRF	NN	I-NP
O	610	613	was	be	VBD	B-VP
O	614	627	progressively	progressively	RB	I-VP
O	628	636	overcome	overcome	VBN	I-VP
O	637	641	with	with	IN	B-PP
O	642	652	increasing	increase	VBG	B-NP
O	653	663	calmodulin	calmodulin	NN	I-NP
O	664	678	concentrations	concentration	NNS	I-NP
O	678	679	,	,	,	O
O	680	684	with	with	IN	B-PP
O	685	687	no	no	DT	B-NP
O	688	698	inhibition	inhibition	NN	I-NP
O	699	707	observed	observe	VBN	B-VP
O	708	710	at	at	IN	B-PP
O	711	712	a	a	DT	B-NP
O	713	723	saturating	saturating	JJ	I-NP
O	724	734	calmodulin	calmodulin	NN	I-NP
O	735	748	concentration	concentration	NN	I-NP
O	748	749	.	.	.	O

O	750	759	Nanomolar	Nanomolar	JJ	B-NP
O	760	774	concentrations	concentration	NNS	I-NP
O	775	777	of	of	IN	B-PP
O	778	782	MLCK	MLCK	NN	B-NP
O	783	790	blocked	block	VBD	B-VP
O	791	794	the	the	DT	B-NP
O	795	804	formation	formation	NN	I-NP
O	805	807	of	of	IN	B-PP
O	808	818	calmodulin	calmodulin	NN	B-NP
O	818	819	-	-	HYPH	B-NP
O	819	820	[	[	(	B-NP
O	820	824	125I	125I	NN	I-NP
O	824	825	-	-	HYPH	I-NP
O	825	830	Tyr10	Tyr10	NN	I-NP
O	830	831	]	]	)	I-NP
O	831	834	VIP	VIP	NN	I-NP
O	835	844	complexes	complex	NNS	I-NP
O	844	845	.	.	.	O

O	846	851	These	These	DT	B-NP
O	852	856	data	datum	NNS	I-NP
O	857	864	provide	provide	VBP	B-VP
O	865	872	support	support	NN	B-NP
O	873	876	for	for	IN	B-PP
O	877	878	a	a	DT	B-NP
O	879	889	functional	functional	JJ	I-NP
O	890	894	role	role	NN	I-NP
O	895	897	of	of	IN	B-PP
O	898	901	VIP	VIP	NN	B-NP
O	902	905	and	and	CC	I-NP
O	906	909	GRF	GRF	NN	I-NP
O	910	917	binding	binding	NN	I-NP
O	918	920	by	by	IN	B-PP
O	921	931	calmodulin	calmodulin	NN	B-NP
O	931	932	.	.	.	O

